While the number of circulating CXCR4+ cells alone may not be a sufficient marker of disease progression in IPF, this study adds to the body of evidence that CXCR4/CXCL12 axis is an important mechanism for development of fibrosis. This evidence concerns the gene CXCL12 and idiopathic pulmonary fibrosis.